| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8661988 | International Journal of Cardiology | 2018 | 35 Pages |
Abstract
The available evidence suggests that NP-guided therapy provides no additional benefit over guideline directed therapy in terms of all-cause mortality and HF-related hospitalizations in acute or chronic HF patients, regardless of their ejection fraction.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Muhammad Shahzeb Khan, Tariq Jamal Siddiqi, Muhammad Shariq Usman, Jayakumar Sreenivasan, Setri Fugar, Haris Riaz, M.H. Murad, Farouk Mookadam, Vincent M. Figueredo,